Bedfordshire, Luton and Milton Keynes Area Prescribing Committee
Ref: APC Bulletin 242 (Last Updated February 2020)
Bulletin Date: 26/02/20
Review Date: February 2023
Bulletin 242: Low Molecular Weight Heparins (LMWHs), Fondaparinux and Novel Oral Anticoagulants – Prescribing Guidance and Responsibilities
Formulary Status - AMBER
Amber medicines are considered suitable for TP prescribing following specialist initiation.
APC Recommendations:
Aims
To support the prescribing and monitoring of treatment and prophylactic doses of LMWHs, Fondaparinux and NOACs across the primary/secondary care interface for venous thromboembolism (VTE).
To support primary care prescribers in the governance and safety of initiating and/or continuing the prescribing of these agents.
Objectives
- Define the place in therapy of LMWH, Fondaparinux and NOACs for primary care prescribers.
- Identify who is responsible for the initiation and continued supply (where relevant) of these agents thereby minimising confusion.
- Ensure that these agents are used safely and appropriately across Bedfordshire and Luton CCGs.
See attached bulletin for full details
Please use the search box to search the whole site if you can't find what you're looking for:
